Use access key #2 to skip to page content.

IBDvalueinvestin (99.66)

H1N1 vaccine costs about $22.50 in China per dose, how much is it in the USA?

Recs

2

June 19, 2009 – Comments (0) | RELATED TICKERS: SVA

Check SVA news today regarding an order it received for 4M doses. Two mln HK people to receive new flu shot for free http://news.xinhuanet.com/english/2009-06/09/content_11515247.htmwww.chinaview.cn 2009-06-09 19:50:37   PrintSinovac Receives China's First Influenza A

    HONG KONG, June 9 (Xinhua) -- Hong Kong Secretary for Food and Health York Chow said Tuesday the government will provide free influenza A/H1N1 vaccines for about two million of the population.

    Speaking at a press conference Tuesday afternoon, Chow said that the executive council has decided to initiate immediately the process for procurement of A/H1N1 flu vaccines for four target groups in the city recommended by the Scientific Committees of the Center for Health Protection of Hong Kong.

    The four target groups includes: healthcare workers in both the public and private sectors; children aged six months or above and below six years old; elderly persons aged 65 and above; and persons at higher risk of death and complications from the new strain flu due to pre-existing medical conditions.

    Since each person requires two doses, the government will order four million doses of vaccines for the above groups which involved about two million people. While an extra one million doses will be ordered for those who wanted to pay for the vaccination.

    The total cost for the vaccination program, which is entirely voluntary, is estimated to be about 700 million HK dollars (about 90.4 million U.S. dollars), according to Chow.

    He said that the government will continue to gather facts from various vaccine manufacturers on the quality, availability and price of the vaccines, to prepare tender for the eventual procurement of the vaccines, and to seek funding approval from the Finance Committee of the Legislative Council later this month.

    Besides, Chow told that the executive council also decided to give those elderly aged 65 and above pneumococcal and seasonal influenza vaccines for free.

    The decision was made because the two vaccines play an important role alongside A/H1N1 flu vaccine in mitigating the impact of an influenza epidemic in Hong Kong by reducing hospitalizations and deaths among elderly people when infected, he said.

---------------------------------------------------------------------------------------------------------------

 Sinovac Receives China's First Influenza A (H1N1) Vaccine Order

Press Release Source: Sinovac Biotech Ltd. On Friday June 19, 2009, 10:00 am EDT

http://finance.yahoo.com/news/Sinovac-Receives-Chinas-First-prnews-1395978367.html?x=0&.v=7

BEIJING, June 19 /PRNewswire-Asia/ --

 Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, announced today that the Company received the first order in China to supply its influenza A (H1N1) vaccine to the Beijing government. The initial order consists of 4 million doses and is expected to be delivered by the end of September. This order will be administered to 2 million people in the high risk group. Additional orders are expected beginning in October and, in total, Sinovac expects to supply approximately 10 million doses to the Beijing government. The 10 million doses will be administered to 5 million people in Beijing.

On June 14, 2009, Sinovac completed construction of the H1N1 virus seed bank necessary to produce a virus antigen and commenced production of the first batch of H1N1 vaccine. Sinovac expects to complete production of the first batch by the end of July.

Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, "We are organizing and coordinating all personnel and resources to produce the H1N1 vaccine, as we have almost completed the production of our seasonal influenza vaccine. With the support and instruction of the relevant government and health authorities, Sinovac will fully utilize its proven development and production abilities from both the H5N1 vaccine and seasonal flu vaccine to ensure the efficient production of the H1N1 vaccine. We are working closely with authorities in order to contribute to the prevention and control of the H1N1 epidemic situation."

0 Comments – Post Your Own

Featured Broker Partners


Advertisement